4C Medical Technologies
Maple Grove, US · Founded 2015 · Delaware corporation
4C Medical develops AltaValve, a supra-annular transcatheter mitral valve replacement (TMVR) system for treating mitral regurgitation. The atrial-anchored device is designed to preserve cardiac structures and treat a broader patient population; it is currently an investigational device.
HealthtechMedical Devices
Founders & leadership
HH
Harley HandegardExecutive
KK
Katherine KumarExecutive
RT
Robert ThatcherExecutive
JF
James FlahertyExecutive
SK
Saravana KumarNamed on SEC filing
Board
JC
Jeffrey ChambersBoard director
JC
Jonathan ChenBoard director
BB
Buzz BensonBoard director
RR
Rhonda RobbBoard director
Reported raises · per SEC filings
Form D private placements$145.5M disclosed across 7 rounds · 2016–2025
▶$71.6MraisedMar 2026 · 80 investors · Other TechnologyRule 506(b)
▶$71.6MraisedMar 2026 · 80 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Jeffrey ChambersDirector
- Jonathan ChenDirector
- Rhonda RobbDirector
- Harley HandegardExecutive Officer
- Katherine KumarExecutive Officer
- Saravana KumarExecutive Officer, Director
- Buzz BensonDirector
- Offering amount
- $166.1M
- Amount sold
- $71.6M
- Sales commissions
- $9.3M
- Placement agents
- Piper Sandler & Co.
- First sale
- Mar 2025
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$35.3MraisedNov 2021 · 53 investors · Other TechnologyRule 506(b)
▶$35.3MraisedNov 2021 · 53 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Saravana KumarExecutive Officer, Director
- Buzz BensonDirector
- Jeffrey W. ChambersDirector
- Rhonda RobbDirector
- Katherine KumarExecutive Officer
- Scott YoungstromExecutive Officer
- Jonathan ChenDirector
- Offering amount
- $60.6M
- Amount sold
- $35.3M
- First sale
- Nov 2021
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$10MraisedJun 2021 · 39 investors · Other TechnologyRule 506(b)
▶$10MraisedJun 2021 · 39 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Scott YoungstromExecutive Officer
- Saravana KumarExecutive Officer, Director
- Buzz BensonDirector
- Katherine KumarExecutive Officer
- Jonathan ChenDirector
- Jeffrey W. ChambersExecutive Officer, Director, Promoter
- Offering amount
- $10M
- Amount sold
- $10M
- First sale
- May 2020
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$8.2MraisedOct 2019 · 45 investors · Other TechnologyRule 506(b)
▶$8.2MraisedOct 2019 · 45 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- William HoffmanDirector
- Katherine KumarExecutive Officer
- Saravana KumarExecutive Officer
- Robert J. ThatcherExecutive Officer, Director
- Jeffrey W. ChambersExecutive Officer, Director, Promoter
- Jonathan ChenDirector
- Buzz BensonDirector
- James E. FlahertyExecutive Officer
- Offering amount
- $20M
- Amount sold
- $8.2M
- First sale
- Sep 2019
- Incorporated
- Corporation, Delaware, 2015
- Federal exemptions
- 06b
▶$17.3MraisedSep 2018 · 23 investors · Other TechnologyRule 506(b)
▶$17.3MraisedSep 2018 · 23 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- William HoffmanDirector
- Katherine KumarExecutive Officer
- James E. FlahertyExecutive Officer
- Saravana KumarExecutive Officer
- Jeffrey W. ChambersExecutive Officer, Director, Promoter
- Robert J. ThatcherExecutive Officer, Director
- Jonathan ChenDirector
- Offering amount
- $25M
- Amount sold
- $17.3M
- First sale
- Sep 2018
- Incorporated
- Corporation, Delaware, 2015
- Federal exemptions
- 06b
▶$3.1MraisedMay 2018 · 29 investors · Other TechnologyRule 506(b)
▶$3.1MraisedMay 2018 · 29 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Jeffrey W. ChambersExecutive Officer, Director, Promoter
- James E. FlahertyExecutive Officer
- Katherine KumarExecutive Officer
- Saravana KumarExecutive Officer
- William HoffmanDirector
- Robert J. ThatcherExecutive Officer, Director
- Offering amount
- $15M
- Amount sold
- $3.1M
- First sale
- Apr 2018
- Incorporated
- Corporation, Delaware, 2015
- Federal exemptions
- 06b
▶$60KraisedDec 2016 · 1 investors · Other TechnologyRule 506(b)
▶$60KraisedDec 2016 · 1 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Robert ThatcherExecutive Officer, Director
- James FlahertyExecutive Officer
- Jeffrey W. ChambersDirector, Promoter
- Offering amount
- $2M
- Amount sold
- $60K
- First sale
- Nov 2016
- Incorporated
- Corporation, Delaware, 2015
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 6
by search overlapMassdevice24 shared keywordsMassDevice is a news and media outlet covering the medical device industry, publishing articles, special reports, and white papers on medtech companies, products, and regulatory topics such as FDA 510(k) submissions. It serves medical device professionals with industry news and analysis.
Edwards Lifesciences21 shared keywords
Rf Surgical21 shared keywordsMedtronic develops healthcare technology, including pulsed field ablation systems used to treat atrial fibrillation (AFib). The company serves clinicians and healthcare providers in the medical device and cardiac care field.
Cardiovalve19 shared keywordsCardiovalve develops a transcatheter valve replacement system designed to fit both mitral and tricuspid anatomies via transfemoral delivery, avoiding open heart surgery. The device targets structural heart disease and is currently restricted to research use.
Boston Scientific14 shared keywordsBoston Scientific supports external researcher-initiated studies through its Investigator Sponsored Research program, which funds independent investigations addressing disease understanding and treatment gaps of interest to the medical community.
Foldax13 shared keywordsCompany advancing product and clinical development in the medical device space.
Companies competing with 4C Medical Technologies for the same Google search keywords, organic and paid, via search-intersection analysis.
Frequently asked questions
- What does 4C Medical Technologies do?
- 4C Medical develops AltaValve, a supra-annular transcatheter mitral valve replacement (TMVR) system for treating mitral regurgitation. The atrial-anchored device is designed to preserve cardiac structures and treat a broader patient population; it is currently an investigational device.
- How much funding has 4C Medical Technologies raised?
- 4C Medical Technologies has disclosed $145.5M raised across 7 rounds.
- Where is 4C Medical Technologies headquartered?
- 4C Medical Technologies is headquartered in Maple Grove, US.